PEDIATRICS Vol. 91 No. 6 June 1993, pp. 1147-1150
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ellis, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellis, R., III

Coagulopathy Screening in Children With Heparinized Central Venous Catheters

Robert Ellis III MC, USAF1

1 From the Departments of Oncology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD.

Objective. To develop a method of screening for coagulopathy using blood drawn through heparinized central venous catheters.

Methods. Prothrombin time (PT) and activated partial thromboplastin time (APTT) were determined in paired blood samples with and without the addition of protamine, using an automated photo-optical method. A concentration of 4 µg/mL of citrated whole blood was chosen, based on preliminary experiments. This is sufficient to neutralize the expected heparin contamination in samples drawn through heparinized catheters while causing only a slight prolongation in APTT (due to the anticoagulant effect of protamine). Seventeen paired samples were drawn by venipuncture in patients without known coagulopathy. Twenty-five samples were drawn through heparinized central venous catheters. The first 5 mL of blood drawn from a catheter was discarded to avoid gross heparin contamination. Four samples from patients with coagulopathy were also analyzed with and without the addition of 2.5 µg/mL of heparin.

Results. Protamine increased PT by 9.0 ± 0.8% and APTT by 9.0 ± 3.4% (mean ± SD) in the samples drawn by venipuncture. For samples drawn through heparinized catheters, 52% had a prolonged APTT 44% a prolonged PT, and 68% had at least one prolonged test. With the addition of protamine, and after correction for the 9% mean increase in PT and APTT, 4% of samples had a prolonged APTT, 12% had a prolonged PT, and 16% had at least one prolonged test (P = .00006, .014, and .0001). All four samples from patients with coagulopathy were correctly identified as abnormal after the addition of protamine, with or without added heparin.

Conclusions. A protamine-supplemented APTT test on blood drawn through a heparinized catheter may be an adequate screening test for coagulopathy. This procedure reduces discomfort in patients with an indwelling catheter by avoiding venipuncture.

Key Words: heparin • protamines • prothrombin time • partial thromboplastin time • blood coagulation disorders • indwelling catheters

Submitted on October 13, 1992
Accepted on December 30, 1992




This article has been cited by other articles:


Home page
Journal of Pediatric Oncology NursingHome page
M. Cash, B. Schafhauser, and J. F. Byers
Venipuncture Versus Central Venous Access: A Comparison of Methotrexate Levels in Pediatric Leukemia Patients
Journal of Pediatric Oncology Nursing, January 1, 1999; 16(4): 189 - 193.
[Abstract] [PDF]